المؤلفون: Yong Li, Aiping Zhou, Shuoyan Liu, Ming He, Keneng Chen, Ziqiang Tian, Yin Li, Jianjun Qin, Zhen Wang, Haiquan Chen, Hui Tian, Yue Yu, Wang Qu, Liyan Xue, Shun He, Shuhang Wang, Fenglong Bie, Guangyu Bai, Bolun Zhou, Zhaoyang Yang, Huiyao Huang, Yan Fang, Benjamin Li, Xiangrong Dai, Shugeng Gao, Jie He

المصدر: BMC Medicine, Vol 21, Iss 1, Pp 1-12 (2023)

مصطلحات موضوعية: PD-L1, Chemotherapy, Neoadjuvant treatment, Esophageal squamous cell carcinoma (ESCC), Major pathological response (MPR), Medicine

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1741-7015Test

الوصول الحر: https://doaj.org/article/95afef0fd3704bb2bf3b853070fbe091Test

المؤلفون: Xin Li, Chunqiu Xia, Minghui Liu, Jinghao Liu, Ming Dong, Honglin Zhao, Song Xu, Dan Wang, Sen Wei, Zuoqing Song, Gang Chen, Hongyu Liu, Jun Chen

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: neoadjuvant immunotherapy, non-small cell lung cancer (NSCLC), camrelizumab, major pathological response (MPR), surgery, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.843116/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/958d21d7e3c9435d85d90243e855301cTest

المؤلفون: Zhao, Guangyin, Zhang, Hongyu, Fengkai, Xu, Chunlai, Lu, Zhu, Qiaoliang, Grossi, Francesco, Divisi, Duilio, Teng, Ma, Jie, Gu, Di, Ge

المصدر: Translational Lung Cancer Research. 12:141-149

مصطلحات موضوعية: Non-small-cell lung cancer (NSCLC), major pathological response (MPR), complete pathological response (CPR), Oncology, treatment-related adverse event (trAE), neoadjuvant therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfef558a15455e78083364ebc478a224Test
https://doi.org/10.21037/tlcr-22-871Test

المؤلفون: Xin Li, Chunqiu Xia, Minghui Liu, Jinghao Liu, Ming Dong, Honglin Zhao, Song Xu, Dan Wang, Sen Wei, Zuoqing Song, Gang Chen, Hongyu Liu, Jun Chen

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, neoadjuvant immunotherapy, non-small cell lung cancer (NSCLC), camrelizumab, major pathological response (MPR), surgery

العلاقة: https://figshare.com/articles/dataset/Table_1_Neoadjuvant_camrelizumab_and_chemotherapy_in_patients_with_resectable_stage_IIIA_squamous_non-small-cell_lung_cancer_Clinical_experience_of_three_cases_docx/21090415Test

الإتاحة: https://doi.org/10.3389/fonc.2022.843116.s001Test
https://figshare.com/articles/dataset/Table_1_Neoadjuvant_camrelizumab_and_chemotherapy_in_patients_with_resectable_stage_IIIA_squamous_non-small-cell_lung_cancer_Clinical_experience_of_three_cases_docx/21090415Test

المؤلفون: Duan, Hongtao, Wang, Tianhu, Luo, Zhilin, Wang, Xiaoyuan, Liu, Honggang, Tong, Liping, Dong, Xiaoping, Zhang, Yong, Valmasoni, Michele, Kidane, Biniam, Almhanna, Khaldoun, Wiesel, Ory, Pang, Sainan, Ma, Jianqun, Yan, Xiaolong

المساهمون: Duan, Hongtao, Wang, Tianhu, Luo, Zhilin, Wang, Xiaoyuan, Liu, Honggang, Tong, Liping, Dong, Xiaoping, Zhang, Yong, Valmasoni, Michele, Kidane, Biniam, Almhanna, Khaldoun, Wiesel, Ory, Pang, Sainan, Ma, Jianqun, Yan, Xiaolong

مصطلحات موضوعية: Sintilimab, efficacy, major pathological response (MPR), pathological complete response (pCR), safety

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34988209; info:eu-repo/semantics/altIdentifier/wos/WOS:000729116100003; volume:9; issue:22; firstpage:1700; lastpage:1700; numberofpages:1; journal:ANNALS OF TRANSLATIONAL MEDICINE; http://hdl.handle.net/11577/3410565Test

الإتاحة: https://doi.org/10.21037/atm-21-6102Test
http://hdl.handle.net/11577/3410565Test

المؤلفون: Liping Tong, Jianqun Ma, Honggang Liu, Ory Wiesel, Xiaoyuan Wang, Biniam Kidane, Zhilin Luo, Michele Valmasoni, Khaldoun Almhanna, Xiaolong Yan, Yong Zhang, Tianhu Wang, Hongtao Duan, Sainan Pang, Xiaoping Dong

المصدر: Ann Transl Med

مصطلحات موضوعية: Oncology, safety, medicine.medical_specialty, Chemotherapy, major pathological response (MPR), business.industry, medicine.medical_treatment, efficacy, pathological complete response (pCR), General Medicine, Esophageal cancer, medicine.disease, Sintilimab, Neoadjuvant treatment, Internal medicine, medicine, Original Article, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0593aad5c944cd8fca6c35fc94503fb7Test
http://hdl.handle.net/11577/3410565Test